Abstract
Watch the video or read the poster to learn aboutWhy mycoplasma contamination poses a significant safety and economic risk to biopharmaceutical manufacturersNucleic acid amplification technique (NAT)-based assays as rapid, sensitive, and reproducible alternatives to direct agar cultureHow fast and accurate mycoplasma detection can support the evolving needs of cell and gene therapy developers through commercial manufacturingJessica Hutcheson over the last decade, has gained extensive involvement in working within several labs focusing on regenerative medicine. With years of lab management experience in the biotech industry and academia, she has developed skills for coordinating and managing a team throughout small- and large-scale projects. Alongside her project management, Jessica has gained skillsets in mammalian cell culture (including a primary cell, stem cell, and induced Pluripotent stem cells), and molecular biology techniques. At Rubhu Biologics she plans to continue to provide both research and administrative support to the company.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
